4 insider filings
John J. Kirby, insider filing for VRCA
Show all 4
- 4Insider filing for VRCA
- 4Insider filing for VRCA
- 4Insider filing for VRCA
- 4Insider filing for VRCA
John J. Kirby, reporting
VRCA
Verrica Pharmaceuticals Inc. SEC filings
Every EDGAR filing for Verrica Pharmaceuticals Inc. (VRCA), newest first, with AI summaries and stories.
- Ticker
- VRCA
- CIK
- 1660334
- Latest filing
- Aug 18
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4Verrica Pharmaceuticals Inc.VRCALIVE NOTABLE10-QVerrica Pharmaceuticals Inc.VRCALIVE ROUTINE8-KVerrica Pharmaceuticals Inc.VRCALIVE ROUTINE4Verrica Pharmaceuticals Inc.VRCALIVE 7 insider filings
Gavin Corcoran, insider filing for VRCA
Show all 7
- 4Insider filing for VRCA
- 4Insider filing for VRCA
- 4Insider filing for VRCA
- 4Insider filing for VRCA
- 4Insider filing for VRCA
- 4Insider filing for VRCA
- 4Insider filing for VRCA
Gavin Corcoran, reporting
ROUTINE8-KVerrica Pharmaceuticals Inc.VRCALIVE ROUTINES-8Verrica Pharmaceuticals Inc.VRCALIVE ROUTINE8-KVerrica Pharmaceuticals Inc.VRCALIVE NOTABLE10-QVerrica Pharmaceuticals Inc.VRCALIVE ROUTINEARSVerrica Pharmaceuticals Inc.VRCALIVE ROUTINEDEFA14AVerrica Pharmaceuticals Inc.VRCALIVE ROUTINEDEF 14AVerrica Pharmaceuticals Inc.VRCALIVE NOTABLE10-KVerrica Pharmaceuticals Inc.VRCALIVE ROUTINE8-KVerrica Pharmaceuticals Inc.VRCALIVE ROUTINESCHEDULE 13G/AVerrica Pharmaceuticals Inc.VRCALIVE Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)
ARMISTICE CAPITAL, LLC, filed by
ROUTINE3/AVerrica Pharmaceuticals Inc.VRCALIVE BKB Growth Investments, LLC, new insider at VRCA (amended)
BKB Growth Investments, LLC, reporting
ROUTINESCHEDULE 13G/AVerrica Pharmaceuticals Inc.VRCALIVE Ownership stake disclosure by Affinity Asset Advisors, LLC (amended)
Affinity Asset Advisors, LLC, filed by
ROUTINE3Verrica Pharmaceuticals Inc.VRCALIVE BKB Growth Investments, LLC, new insider at VRCA
BKB Growth Investments, LLC, reporting
ROUTINE4Verrica Pharmaceuticals Inc.VRCALIVE 3 insider filings
John J. Kirby, insider filing for VRCA
Show all 3
- 4Insider filing for VRCA
- 3New insider at VRCA
- 3New insider at VRCA
John J. Kirby, reporting
NOTABLESCHEDULE 13D/AVerrica Pharmaceuticals Inc.VRCALIVE Ownership stake disclosure by Caligan Partners LP (amended)
Caligan Partners LP, filed by
ROUTINE8-KVerrica Pharmaceuticals Inc.VRCALIVE ROUTINEEFFECTVerrica Pharmaceuticals Inc.VRCALIVE ROUTINE424B3Verrica Pharmaceuticals Inc.VRCALIVE ROUTINES-3Verrica Pharmaceuticals Inc.VRCALIVE ROUTINEDVerrica Pharmaceuticals Inc.VRCALIVE ROUTINESCHEDULE 13GVerrica Pharmaceuticals Inc.VRCALIVE Ownership stake disclosure by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC, filed by
NOTABLESCHEDULE 13D/AVerrica Pharmaceuticals Inc.VRCALIVE Ownership stake disclosure by Paul B Manning (amended)
Paul B Manning, filed by
ROUTINE4Verrica Pharmaceuticals Inc.VRCALIVE 5 insider filings
Noah L. Rosenberg, insider filing for VRCA
Show all 5
- 4Insider filing for VRCA
- 4Insider filing for VRCA
- 4Insider filing for VRCA
- 4Insider filing for VRCA
- 4Insider filing for VRCA
Noah L. Rosenberg, reporting
NOTABLESCHEDULE 13DVerrica Pharmaceuticals Inc.VRCALIVE Verrica Pharmaceuticals Inc. filed SCHEDULE 13D
- Form Type: SCHEDULE 13D
- Filing Date: 2025-11-24
Caligan Partners LP, filed by
ROUTINESCHEDULE 13G/AVerrica Pharmaceuticals Inc.VRCALIVE Verrica Pharmaceuticals Inc. (VRCA) filed a Schedule 13G/A, disclosing that ARMISTICE CAPITAL, LLC has reported a 5.2% ownership stake in the company.
ARMISTICE CAPITAL, LLC, filed by
NOTABLE10-QVerrica Pharmaceuticals Inc.VRCALIVE ROUTINE8-KVerrica Pharmaceuticals Inc.VRCALIVE